The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Luteal phase support for assisted reproduction cycles
Open accessAbstract
BACKGROUND: Progesterone prepares the endometrium for pregnancy by stimulating proliferation in response to human chorionic gonadotropin(hCG) produced by the corpus luteum. This occurs in the luteal phase of the menstrual cycle. In assisted reproduction techniques(ART), progesterone and/or hCG levels are low, so the luteal phase is supported with progesterone, hCG or gonadotropin-releasing hormone (GnRH) agonists to improve implantation and pregnancy rates. OBJECTIVES: To determine the relative effectiveness and safety of methods of luteal phase support provided to subfertile women undergoing assisted reproduction. SEARCH METHODS: We searched databases including the Cochrane Menstrual Disorders and Subfertility Group (MDSG) Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO and trial registers. We conducted searches in November 2014, and further searches on 4 August 2015. SELECTION CRITERIA: Randomised controlled trials (RCTs) of luteal phase support using progesterone, hCG or GnRH agonist supplementation in ART cycles. DATA COLLECTION AND ANALYSIS: Three review authors independently selected trials, extracted data and assessed risk of bias. We calculated odds ratios (ORs) and 95%confidence intervals (CIs) for each comparison and combined data when appropriate using a fixed-effect model. Our primary out come was live birth or ongoing pregnancy. The overall quality of the evidence was assessed using GRADE methods. MAIN RESULTS: Ninety-four women RCTs (26,198 women) were included. Most studies had unclear or high risk of bias in most domains. The main limitations in the evidence were poor reporting of study methods and imprecision due to small sample sizes.1. hCG vs placebo/no treatment (five RCTs, 746 women)There was no evidence of differences between groups in live birth or ongoing pregnancy (OR 1.67, 95% CI 0.90 to 3.12, three RCTs,527 women, I2 = 24%, very low-quality evidence, but I2 of 61% was found for the subgroup of ongoing pregnancy) with a random effects model. hCG increased the risk of ovarian hyperstimulation syndrome (OHSS) (1 RCT, OR 4.28, 95% CI 1.91 to 9.6, low quality evidence).2. Progesterone vs placebo/no treatment (eight RCTs, 875 women)Evidence suggests a higher rate of live birth or ongoing pregnancy in the progesterone group (OR 1.77, 95% CI 1.09 to 2.86, five RCTs, 642 women, I2 = 35%, very low-quality evidence). OHSS was not reported.3. Progesterone vs hCG regimens (16 RCTs, 2162 women)hCG regimens included comparisons of progesterone versus hCG and progesterone versus progesterone + hCG. No evidence showed differences between groups in live birth or ongoing pregnancy (OR 0.95, 95% CI 0.65 to 1.38, five RCTs, 833 women, I2 = 0%, low quality evidence) or in the risk of OHSS (four RCTs, 615 women, progesterone vs hCG OR 0.54, 95% CI 0.22 to 1.34; four RCTs,678 women; progesterone vs progesterone plus hCG, OR 0.34, 95% CI 0.09 to 1.26, low-quality evidence).4. Progesterone vs progesterone with oestrogen (16 RCTs, 2577 women)No evidence was found of differences between groups in live birth or ongoing pregnancy (OR 1.12, 95% CI 0.91 to 1.38, nine RCTs,1651 women, I2 = 0%, low-quality evidence) or OHSS (OR 0.56, 95% CI 0.2 to 1.63, two RCTs, 461 women, I2 = 0%, low-quality evidence).5. Progesterone vs progesterone + GnRH agonist (seven RCTs, 1708 women)Live birth or ongoing pregnancy rates were lower in the progesterone-only group and increased in women who received progester one and one or more GnRH agonist doses (OR 0.62, 95% CI 0.48 to 0.81, nine RCTs, 2861 women, I2 = 55%, random effects, low quality evidence). Statistical heterogeneity for this comparison was high because of unexplained variation in the effect size, but the direction of effect was consistent across studies. OHSS was reported in one study only (OR 1.00, 95% CI 0.33 to 3.01, 1 RCT, 300 women, very low quality evidence).6. Progesterone regimens (45 RCTs, 13,814 women)The included studies reported nine different comparisons between progesterone regimens. Findings for live birth or ongoing pregnancy were as follows: intramuscular (IM) versus oral: OR 0.71, 95% CI 0.14 to 3.66 (one RCT, 40 women, very low-quality evidence);IM versus vaginal/rectal: OR 1.24, 95% CI 1.03 to 1.5 (seven RCTs, 2309 women, I2 = 71%, very low-quality evidence); vaginal/rectal versus oral: OR 1.19, 95% CI 0.83 to 1.69 (four RCTs, 857 women, I2 = 32%, low-quality evidence); low-dose versus high-dose vaginal: OR 0.97, 95% CI 0.84 to 1.11 (five RCTs, 3720 women, I2 = 0%, moderate-quality evidence); short versus long protocol:OR 1.04, 95% CI 0.79 to 1.36 (five RCTs, 1205 women, I2 = 0%, low-quality evidence); micronised versus synthetic: OR 0.9, 95%CI 0.53 to 1.55 (two RCTs, 470 women, I2 = 0%, low-quality evidence); vaginal ring versus gel: OR 1.09, 95% CI 0.88 to 1.36 (oneRCT, 1271 women, low-quality evidence); subcutaneous versus vaginal gel: OR 0.92, 95% CI 0.74 to 1.14 (two RCTs, 1465 wome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Luteal phase support in assisted reproduction cycles
Daya, S., & Gunby, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004830 · Cited by 179
RetractedGhanem, M. E., Sadek, E. E., Elboghdady, L. A., Helal, A. S., Gamal, A., Eldiasty, A., Bakre, N. I., & Houssen, M. E. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.1717 · Cited by 24
RetractedCochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
ESTABLISHING FULL‐TERM HUMAN PREGNANCIES USING CLEAVING EMBRYOS GROWN IN VITRO*
Edwards, R. G., Steptoe, P. C., & Purdy, J. M. (1980) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1980.tb04610.x · Cited by 597
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE
de Mouzon, J., Goossens, V., Bhattacharya, S., Castilla, J. A., Ferraretti, A. P., Korsak, V., Kupka, M., Nygren, K. G., Nyboe Andersen, A., & The European IVF-monitoring (EIM) Consortium, F. T. E. S. O. H. R. A. E. (. (2010) · Human Reproduction · doi:10.1093/humrep/deq124 · Cited by 414
Humaidan, P., Polyzos, N. P., Alsbjerg, B., Erb, K., Mikkelsen, A. L., Elbaek, H. O., Papanikolaou, E. G., & Andersen, C. Y. (2013) · Human Reproduction · doi:10.1093/humrep/det249 · Cited by 213
Textbook of Assisted Reproductive Techniques. Laboratory and Clinical Perspectives
(2005) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.0854b.x · Cited by 186
Nyboe Andersen, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.357 · Cited by 164
Mochtar, M. H., Van der Veen, F., Ziech, M., van Wely, M., & Musters, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005070.pub2 · Cited by 160
Smitz, J. E. J., Devroey, P., Faguer, B., Bourgain, C., Camus, M., & Steirteghem, A. C. V. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137611 · Cited by 139
Tesařík, J. (2004) · Human Reproduction · doi:10.1093/humrep/deh235 · Cited by 128
Myers, E. R., McCrory, D. C., Mills, A. A., Price, T. M., Swamy, G. K., Tantibhedhyangkul, J., Wu, J. M., & Matchar, D. B. (2008) · Cited by 126
Luteal phase progesterone increases live birth rate after frozen embryo transfer
Bjuresten, K., Landgren, B.-M., Hovatta, O., & Stavreus-Evers, A. C. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.05.019 · Cited by 122
Smitz, J. E. J., Bourgain, C., Waesberghe, L. V., Camus, M., Devroey, P., & Steirteghem, A. C. V. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137871 · Cited by 105
Pirard, C., Donnez, J., & Loumaye, E. (2005) · Human Reproduction · doi:10.1093/humrep/deh830 · Cited by 101
Experience with a novel vaginal progesterone preparation in a donor oocyte program
Gibbons, W. E., Toner, J. P., Hamacher, P., & Kolm, P. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00457-3 · Cited by 100
Łukaszuk, K., Liss, J., Łukaszuk, M., & Maj, B. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.055 · Cited by 100
Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study
Licciardi, F. L., Kwiatkowski, A., Noyes, N. L., Berkeley, A. S., Krey, L. C., & GRIFO, J. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00515-9 · Cited by 99
Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium
Schindler, A. E. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.10.011 · Cited by 94
Pirard, C., Loumaye, E., Laurent, P., & Wyns, C. (2015) · International Journal of Endocrinology · doi:10.1155/2015/727569 · Cited by 93
The luteal phase after 3 decades of IVF: what do we know?
Fatemi, H. M. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61065-6 · Cited by 90
Luteal support: Progestogens for pregnancy protection
Daya, S. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.09.012 · Cited by 84
Luteal phase support for assisted reproduction cycles
van der Linden, M., Buckingham, K., Farquhar, C. M., Kremer, J. A. M., & Metwally, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009154.pub2 · Cited by 84
Self-citationBioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women
Chan, C. (2003) · Human Reproduction · doi:10.1093/humrep/deg446 · Cited by 83
Improving the luteal phase after ovarian stimulation: reviewing new options
Andersen, C. Y., & Andersen, K. V. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.01.012 · Cited by 81
Kerin, J. F., Broom, T. J., Ralph, M. M., EDMONDS, D. K., Warnes, G. M., Jeffrey, R., Crocker, J. M., Godfrey, B., Cox, L. W., Seamark, R. F., et al. (1981) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb01691.x · Cited by 80
Kyrou, D., Kolibianakis, E. M., Fatemi, H. M., Tarlatzi, T. B., Devroey, P., & Tarlatzis, B. C. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr029 · Cited by 73
Saal, W., GLOWANIA, H.-J., Hengst, W., & Happ, J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54476-8 · Cited by 70
Kaser, D. J., Ginsburg, E. S., Missmer, S. A., Correia, K. F. B., & Racowsky, C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.007 · Cited by 70
Šimunić, V., Tomić, V., Tomić, J., & Nižić, D. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.067 · Cited by 67
Mochtar, M. H., Hogerzeil, H. V., & Mol, B. W. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019453 · Cited by 64
Unfer, V., Casini, M. L., Gerli, S., Costabile, L., Mignosa, M., & Renzo, G. C. D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.934 · Cited by 61
Liu, X., Mu, H.-Q., Shi, Q., Xiao, X., & Qi, H. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-107 · Cited by 61
Kleinstein, J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.073 · Cited by 57
LEETON, J. F., Trounson, A. O., & Jessup, D. (1985) · Journal of Assisted Reproduction and Genetics · doi:10.1007/bf01131506 · Cited by 55
Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone
Patki, A. S., & Pawar, V. C. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701584857 · Cited by 54
Artini, P. G., Volpe, A., Angioni, S. L., Galassi, M. C., Battaglia, C., & Genazzani, A. R. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349699 · Cited by 52
Görkemli, H., Ak, D., Akyurek, C., Aktan, M., & Duman, S. (2004) · Gynecologic and Obstetric Investigation · doi:10.1159/000079115 · Cited by 51
Escribá, M.-J., Bellver, J., Bosch, E., Sánchez, M., Pellicer, A., & Remohi, J., Sr. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.048 · Cited by 51
Early luteal serum progesterone concentrations are higher in pregnancy cycles
Yovich, J. L., McColm, S. C., Yovich, J. M., & MATSON, P. L. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48733-9 · Cited by 50
Ata, B., Yakın, K., Balaban, B., & Urman, B. (2008) · Human Reproduction · doi:10.1093/humrep/dem421 · Cited by 48
Kupferminc, M. J., Lessing, J. B., Amit, A., et al. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137087 · Cited by 47
Lee, V. C. Y., Li, R., Ng, E. H. Y., Yeung, W. S. B., & Ho, P. C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.02.005 · Cited by 44
Luteal phase support in assisted reproductive technology
Pabuçcu, R., & Akar, M. E. (2005) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000169105.62257.e3 · Cited by 43
Zegers-Hochschild, F. (2000) · Human Reproduction · doi:10.1093/humrep/15.10.2093 · Cited by 43
Blake, E. J., Norris, P. M., Dorfman, S. F., Longstreth, J. A., & Yankov, V. I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.014 · Cited by 38
Kyrou, D., Fatemi, H. M., Zepiridis, L. I., Riva, A., Papanikolaou, E. G., Tarlatzis, B. C., & Devroey, P. (2011) · Human Reproduction · doi:10.1093/humrep/der012 · Cited by 37
Assessment and Hormonal Treatment of the Luteal Phase of In Vitro Fertilization Cycles
Yovich, J. L., Stanger, J. D., Yovich, J. M., & SRN, A. I. T. (1984) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1984.tb01472.x · Cited by 34
The Effect of Human Chorionic Gonadotropin and Pregnancy on the Circulating Level of Relaxin
Johnson, M. R., Okokon, E. V., Collins, W. P., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-5-1042 · Cited by 32
Ng, E. H. Y., Chan, C. C. W., Tang, O. S., & Ho, P. C. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.07.023 · Cited by 31
Beckers, N. G. M., Platteau, P., Eijkemans, M. J. C., Macklon, N. S., de Jong, F. H., Devroey, P., & Fauser, B. C. J. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02199 · Cited by 30
García-Velasco, J. A., Motta, L., López, A., et al. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.035 · Cited by 27
Does luteal estradiol supplementation have a role in long agonist cycles?
Elgindy, E. A., El-Haieg, D. O., Mostafa, M. I., & Shafiek, M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.066 · Cited by 27
Drakakis, P., Loutradis, D., Vomvolaki, E., Stefanidis, K., Kiapekou, E., Anagnostou, E., Anastasiadou, K., Milingos, S. D., & Antsaklis, A. J. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701664923 · Cited by 24
GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study
Aboulghar, M. A., Marie, H., Amin, Y. M., Aboulghar, M. M., Nasr, A. M., Serour, G. I., & Mansour, R. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.09.017 · Cited by 24
Smitz, J. E. J., Devroey, P., Faguer, B., Bourgain, C., Camus, M., & Steirteghem, A. C. V. (1992) · PubMed · Cited by 24
Germond, M., Capelli, P., Bruno, G., Vesnaver, S., Senn, A. P., Rouge, N., & Biollaz, J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02979-x · Cited by 23
Majumdar, A., & Inamdar, D. B. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.106341 · Cited by 23
Moini, A., Modarres, S. Z., Amirchaghmaghi, E., Mirghavam, N., Khafri, S., Akhoond, M. R., & Yazdi, R. S. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.20613 · Cited by 21
Stovall, D. W., Voorhis, B. J. V., Sparks, A. E., Adams, L. M., & Syrop, C. H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00356-2 · Cited by 19
Hurd, W. W., Randolph, J. F., Christman, G. M., Ansbacher, R., Menge, A. C., & Gell, J. S. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58572-0 · Cited by 19
Wong, Y. F., Loong, E. P. L., Mao, K. R., et al. (1990) · Reproduction Fertility and Development · doi:10.1071/rd9900351 · Cited by 18
Karaca, N., Akpak, Y. K., Oral, S., Durmus, T., & Yilmaz, R. (2015) · PubMed Central · Cited by 18
Messinis, I., Messini, C., & Dafopoulos, K. C. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61066-8 · Cited by 17
Aghahosseini, M., Aleyassin, A., Khodaverdi, S., Esfahani, F., Mohammadbeigi, R., Movahedi, S., Valeshabad, A. K., Mahdavi, A., Fallahi, P., Shabani, P., et al. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9595-8 · Cited by 17
Unfer, V., Casini, M. L., Costabile, L., Gerli, S., Baldini, D., & Renzo, G. C. D. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62104-9 · Cited by 15
Oral micronized progesterone combined with vaginal progesterone gel for luteal support
Tomić, V., Tomić, J., & Klaić, Đ. Ž. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.569791 · Cited by 14
Luteal phase support in assisted reproduction cycles
Daya, S., Gunby, J. L., & Ogah, J. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004830.pub2 · Cited by 12
Chang, H. J., Lee, J. R., Jee, B. C., Suh, C. S., & Kim, S. H. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.2.262 · Cited by 11
Gazvani, R., Russell, R., Sajjad, Y., & Alfirević, Ž. (2012) · Trials · doi:10.1186/1745-6215-13-118 · Cited by 9
Şatir, F., Toptaş, T., İNEL, M., Akar, M. E., & Taşkın, Ö. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1049 · Cited by 8
Baber, R., Kuan, R., Porter, R. N., & Saunders, D. M. (1988) · Asia-Oceania Journal of Obstetrics and Gynaecology · doi:10.1111/j.1447-0756.1988.tb00133.x · Cited by 8
Abu-Musa, A. A., Usta, I. M., Nassar, A. H., Hajami, F., & Hannoun, A. B. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.043 · Cited by 6
Kwon, S.-K., Kim, C.-H., Ahn, J.-W., Lee, K.-H., Chae, H. D., & Kang, B.-M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.958 · Cited by 4
Özçimen, E. E., Uğur, M., Özçimen, N., et al. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.361 · Cited by 3
Mochtar, M. H., van Wely, M., & van der Veen, F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005070 · Cited by 3
Cited by
Ruiz-Alonso, M., Blesa, D., Díaz-Gimeno, P., Gómez, E., Fernández-Sánchez, M., Carranza, F., Carrera, J., Vilella, F., Pellicer, A., & Simón, C. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.004 · Cited by 560
ESHRE guideline: ovarian stimulation for IVF/ICSI†
The ESHRE Guideline Group on Ovarian Stimulation, Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., Kunicki, M., La Marca, A., Lainas, G., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa009 · Cited by 543
Regulatory T cells in embryo implantation and the immune response to pregnancy
Robertson, S. A., Care, A. S., & Moldenhauer, L. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122182 · Cited by 462
Groenewoud, E. R., Cantineau, A. E. P., Kollen, B. J., Macklon, N. S., & Cohlen, B. J. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt030 · Cited by 306
Niederberger, C., Pellicer, A., Cohen, J., Gardner, D. K., Palermo, G. D., O’Neill, C. L., Chow, S., Rosenwaks, Z., Cobo, A., Swain, J. E., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.005 · Cited by 301
Metadata
- Authors
- van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J. A., & Metwally, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-07-07
- Volume
- 2016
- Issue
- 10
- Pages
- CD009154-CD009154
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2473943285
- Cited by
- 467
- References
- 76
- FWCI
- 45.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.